Cargando…
ODP142 Concentric Reversible Visual Field Loss, Nyctalopia and Dyschromatopsia With Ezetimibe Therapy - A Case Report
BACKGROUND: Ezetimibe is a lipid lowering agent that selectively inhibits intestinal cholesterol absorption. It is clinically indicated in patients with hypercholesterolemia in combination with statin or as monotherapy in patients who are contraindicated or intolerant to statin. Musculoskeletal and...
Autores principales: | Xu, Zhengchao, Preda, Veronica, Jabbour, James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625016/ http://dx.doi.org/10.1210/jendso/bvac150.493 |
Ejemplares similares
-
Concentric Reversible Visual Field Loss, Nyctalopia, and Dyschromatopsia with Ezetimibe Therapy
por: Xu, Zhengchao, et al.
Publicado: (2023) -
Nyctalopia in India
por: Gupta, Hari Charan
Publicado: (1905) -
On Nyctalopia, or Night-Blindness
Publicado: (1816) -
Observations on Tropical Nyctalopia
por: Forbes, John
Publicado: (1811) -
SUN-543 Real World Evidence of Successful Weight Management for the Obese Population: Complete Reversal of Obesity Related Metabolic Co-Morbidities and Weight Loss in Patients Attending a Multidisciplinary Weight Management Clinic in Australia
por: Rock, Zoe, et al.
Publicado: (2020)